Coffee consumption and risk of renal cell carcinoma
- PMID: 28647866
- PMCID: PMC5782814
- DOI: 10.1007/s10552-017-0913-z
Coffee consumption and risk of renal cell carcinoma
Abstract
Background: Studies have suggested an inverse association between coffee consumption and risk of renal cell carcinoma (RCC); however, data regarding decaffeinated coffee are limited.
Methods: We conducted a case-control study of 669 incident RCC cases and 1,001 frequency-matched controls. Participants completed identical risk factor questionnaires that solicited information about usual coffee consumption habits. The study participants were categorized as non-coffee, caffeinated coffee, decaffeinated coffee, or both caffeinated and decaffeinated coffee drinkers. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression, adjusting for multiple risk factors for RCC.
Results: Compared with no coffee consumption, we found an inverse association between caffeinated coffee consumption and RCC risk (OR 0.74; 95% CI 0.57-0.99), whereas we observed a trend toward increased risk of RCC for consumption of decaffeinated coffee (OR 1.47; 95% CI 0.98-2.19). Decaffeinated coffee consumption was associated also with increased risk of the clear cell RCC (ccRCC) subtype, particularly the aggressive form of ccRCC (OR 1.80; 95% CI 1.01-3.22).
Conclusions: Consumption of caffeinated coffee is associated with reduced risk of RCC, while decaffeinated coffee consumption is associated with an increase in risk of aggressive ccRCC. Further inquiry is warranted in large prospective studies and should include assessment of dose-response associations.
Keywords: Clear cell renal cell carcinoma; Coffee; Decaffeinated coffee; Kidney cancer; RCC; Renal cell carcinoma.
Conflict of interest statement
Similar articles
-
Coffee, decaffeinated coffee, tea intake, and risk of renal cell cancer.Nutr Cancer. 2009;61(1):76-80. doi: 10.1080/01635580802670754. Nutr Cancer. 2009. PMID: 19116877
-
Coffee consumption and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study.Int J Epidemiol. 2021 Nov 10;50(5):1473-1481. doi: 10.1093/ije/dyab011. Int J Epidemiol. 2021. PMID: 33624757 Free PMC article.
-
Association between coffee consumption and risk of renal cell carcinoma: a meta-analysis.Intern Med J. 2017 Dec;47(12):1422-1432. doi: 10.1111/imj.13621. Intern Med J. 2017. PMID: 28892303
-
Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis.Diabetes Care. 2014 Feb;37(2):569-86. doi: 10.2337/dc13-1203. Diabetes Care. 2014. PMID: 24459154 Free PMC article. Review.
-
Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.BMJ Open. 2017 May 9;7(5):e013739. doi: 10.1136/bmjopen-2016-013739. BMJ Open. 2017. PMID: 28490552 Free PMC article. Review.
Cited by
-
Food groups and urologic cancers risk: a systematic review and meta-analysis of prospective studies.Front Nutr. 2023 May 17;10:1154996. doi: 10.3389/fnut.2023.1154996. eCollection 2023. Front Nutr. 2023. PMID: 37266130 Free PMC article. Review.
-
Coffee and caffeine consumption and risk of renal cell carcinoma: A Mendelian randomization study.Front Nutr. 2022 Aug 22;9:898279. doi: 10.3389/fnut.2022.898279. eCollection 2022. Front Nutr. 2022. PMID: 36071939 Free PMC article.
-
Caffeine Targets G6PDH to Disrupt Redox Homeostasis and Inhibit Renal Cell Carcinoma Proliferation.Front Cell Dev Biol. 2020 Oct 6;8:556162. doi: 10.3389/fcell.2020.556162. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33123534 Free PMC article.
References
-
- Sun M, et al. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol. 2011;59(1):135–41. - PubMed
-
- Benichou J, et al. Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol. 1998;148(5):424–30. - PubMed
-
- Ljungberg B, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60(4):615–21. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
